Investment Thesis

.

Competitive Moat

DaVita benefits from strong network effects and high switching costs inherent in the healthcare sector, particularly in chronic disease management. The company’s extensive network of 2,815 outpatient dialysis centers, combined with a robust infrastructure for care coordination, creates a significant barrier for new entrants. Additionally, DaVita’s established relationships with payers and healthcare systems solidify its competitive position. Over the next 5-10 years, this moat is expected to remain durable, although competitive threats from emerging outpatient care models and specialized nephrology practices could pose challenges.

Growth Engine

Future revenue growth for DaVita will largely stem from its expansion in integrated care models and outpatient dialysis services, capitalizing on a total addressable market (TAM) that is projected to grow significantly due to rising incidences of chronic kidney disease. As the company continues to innovate and enhance its service offerings, including home dialysis and telehealth solutions, it is well-positioned to capture market share from competitors. Moreover, while DaVita has experienced organic growth through its existing centers, strategic acquisitions could further bolster its presence in untapped markets, especially internationally, where there is considerable room for expansion.